Inna Serganova
- Molecular Biology top 5%
- Oncology top 2%
- Cancer Research top 2%
- Genetics top 5%
- Biomedical Engineering top 5%
- Co-authors
- Ronald G. BlasbergVladimir PonomarevMikhail DoubrovinJoan MassaguéYibin KangWilliam L. GeraldGaorav P. GuptaAndy J. Minn
- Topics
- Cancer, Hypoxia, and Metabolism (22 papers)Virus-based gene therapy research (18 papers)bioluminescence and chemiluminescence research (15 papers)
- Cited by
- Cancer ResearchOncologyBiotechnology
- Journals
- Proceedings of the National Academy of SciencesJournal of Clinical InvestigationSHILAP Revista de lepidopterología
- Partner nations
- United StatesAustriaNetherlands
In The Last Decade
Inna Serganova
65 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Molecular Biology 1.8k
- Oncology 1.2k
- Cancer Research 923
- Genetics 646
- Biomedical Engineering 493
Countries citing papers authored by Inna Serganova
This map shows the geographic impact of Inna Serganova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inna Serganova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inna Serganova more than expected).
Fields of papers citing papers by Inna Serganova
This network shows the impact of papers produced by Inna Serganova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inna Serganova. The network helps show where Inna Serganova may publish in the future.
Co-authorship network of co-authors of Inna Serganova
This figure shows the co-authorship network connecting the top 25 collaborators of Inna Serganova. A scholar is included among the top collaborators of Inna Serganova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inna Serganova. Inna Serganova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 10 | |
| 5 | 47 | |
| 6 | 12 | |
| 7 | 88 | |
| 8 | 57 | |
| 9 | 49 | |
| 10 | Radionuclide-based reporter gene imaging: pre-clinical and clinical implementation and application | 5 |
| 11 | 28 | |
| 12 | 90 | |
| 13 | 59 | |
| 14 | 42 | |
| 15 | 80 | |
| 16 | 92 | |
| 17 | Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumorsbreakdown → | 522 |
| 18 | 89 | |
| 19 | 44 | |
| 20 | 6 |
About Inna Serganova
Inna Serganova is a scholar working on Biotechnology, Cancer Research and Biophysics, having authored 65 papers that have together received 3.5k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (22 papers), Virus-based gene therapy research (18 papers) and bioluminescence and chemiluminescence research (15 papers). The work is most often cited by research in Cancer Research (923 citations), Oncology (1.2k citations) and Biotechnology (377 citations). Inna Serganova has collaborated with scholars based in United States, Austria and Netherlands. Frequent co-authors include Ronald G. Blasberg, Vladimir Ponomarev, Mikhail Doubrovin, Joan Massagué, Yibin Kang, William L. Gerald, Gaorav P. Gupta, Andy J. Minn, Dilip D. Giri and Jelena Vider. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.